SPONSOR

Insel Gruppe AG, University Hospital Bern

Total Trials

Recruiting

Phases

Phase 2, Phase 4, Phase 1, Phase 3

Conditions studied: Multiple Myeloma Myeloma Lymphoma Leukemia MINOCA Atrial Fibrillation Ischemic Stroke Thrombotic Thrombocytopenic Purpura Congenital Thrombotic Thrombocytopenic Purpura Familial Thrombotic Thrombocytopenic Purpura

Insel Gruppe AG, University Hospital Bern is a clinical research sponsor with 29 registered studies on ClinicalTrials.gov, of which 29 are actively recruiting participants. Research covers conditions including Multiple Myeloma, Myeloma, Lymphoma, Leukemia.

The trial portfolio spans Phase 2, Phase 4, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Insel Gruppe AG, University Hospital Bern

How many clinical trials has Insel Gruppe AG, University Hospital Bern sponsored?

ClinicalMetric currently tracks 29 clinical trials sponsored by Insel Gruppe AG, University Hospital Bern, of which 29 are actively recruiting participants. These trials cover conditions including Multiple Myeloma, Myeloma, Lymphoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.

What therapeutic areas does Insel Gruppe AG, University Hospital Bern research focus on?

Insel Gruppe AG, University Hospital Bern clinical trials span Multiple Myeloma, Myeloma, Lymphoma, Leukemia, MINOCA, and additional conditions. The research pipeline includes Phase 2, Phase 4, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.

How do I participate in a Insel Gruppe AG, University Hospital Bern clinical trial?

To participate in a Insel Gruppe AG, University Hospital Bern trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Insel Gruppe AG, University Hospital Bern trials with current recruitment status updated daily.

Insel Gruppe AG, University Hospital Bern

Frequently Asked Questions — Insel Gruppe AG, University Hospital Bern

Clinical Trials by Insel Gruppe AG, University Hospital Bern

Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients

PRONTO Trial (PRophylactic Versus ON-demand Use of TOcilizumab)

Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA

Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants

Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)

Fremanezumab for the Prevention of Menstrually-related Migraine Attacks

Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and Direct Oral Anticoagulants Intake

Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

Bern Human Organoid-Study to Study Host-microbe Interaction

Questionnaire on Congenital Cancer Signs Through Self-Assessment

Acceptability of the Somnomat Casa for the Treatment of Parkinson's Disease

Prevalence of Attributable Etiology and Modifiable Stroke Risk Factors in Patients With Covert Brain Infarctions

The Voice as a Tool to Detect Recurrence of Laryngeal and Hypopharyngeal Cancer

Maximal Medical Treatment of Intracerebral Haemorrhage Pilot Trial - MAX-ICH Pilot Trial

Point-of-care-ultrasound in Swiss Air Rescue Rega

Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients

Artificial Intelligence in Molecular Imaging: Predicting Parkinson's Risk in REM Sleep Behavior Disorder

Influence of Oxygen on Perioperative Outcome in Patients Undergoing General Anaesthesia for Elective Non-cardiac Surgery

Safety of Biliary Intraductal Radiofrequency Ablation in Patients With Unresectable Extrahepatic Biliary Tract Cancer

Coronary Artery Disease Assessment Strategies in TAVI Patients

Dietary Treatment Strategies and Metabolic Control in Glycogen Storage Disease Type I

Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in Patients With Liver Cirrhosis

SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease

ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer

Giving Children a Voice in Paediatric Anaesthesia

International Validation of Two Non-motor Scales in PD (NFS and SPARK)

High Dose Steroids in Children With Stroke

Pediatric Research in the Outpatient Setting CoHort

Impact of Subthalamic Nucleus Deep Brain Stimulation on COGnitive and PSYchiatric Symptoms in Parkinson's Disease